Trial Profile
Utilizing fMRI to Determine the Effects of Vyvanse on Memory, Attention, and Brain Activity in Menopausal Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Cognition disorders
- Focus Pharmacodynamics
- 02 May 2014 Trial status changed to completed as reported by ClinicalTrials.go.
- 13 Nov 2013 New trial record